Author

Vasileios C Kyttaris

Beth Israel Deaconess Medical Center - Cited by 6,961 - Systemic Lupus Erythematosus

Biography

Dr. Vasileios C. Kyttaris is an Assistant Professor of Medicine at Beth Israel Deaconess Medical Center, Division of Rheumatology, and Harvard Medical School in the USA. He has clinical interests in Systemic Lupus Erythematosus, Rheumatoid Arthritis, and other systemic autoimmune diseases. Dr. Vasileios C. Kyttaris has board certifications from the American Board of Internal Medicine and the American Board of Internal Medicine (Rheumatology).
Title
Cited by
Year
The CD38/NAD/SIRTUIN1/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections
E Katsuyama, A Suarez-Fueyo, SJ Bradley, M Mizui, AV Marin, L Mulki, ...Cell reports 30 (1), 112-123. e4, 2020202
111
2020
Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus‐like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis
M Kono, N Yoshida, K Maeda, A Suárez‐Fueyo, VC Kyttaris, GC TsokosArthritis & Rheumatology 71 (11), 1869-1878, 2019201
64
2019
Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation
M Kono, N Yoshida, K Maeda, NE Skinner, W Pan, VC Kyttaris, ...Proceedings of the National Academy of Sciences 115 (37), 9288-9293, 2018201
51
2018
Novel treatments in lupus
M Vukelic, Y Li, VC KyttarisFrontiers in immunology 9, 2658, 2018201
37
2018
Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus
T Katsuyama, IJ Martin-Delgado, SM Krishfield, VC Kyttaris, VR MoultonRheumatology 59 (8), 2146-2155, 2020202
26
2020
Downregulation of CD3ζ in NK cells from systemic lupus erythematosus patients confers a proinflammatory phenotype
A Suárez-Fueyo, SJ Bradley, T Katsuyama, S Solomon, E Katsuyama, ...The Journal of Immunology 200 (9), 3077-3086, 2018201
21
2018
Signaling lymphocytic activation molecule family member 1 engagement inhibits T cell–B cell interaction and diminishes interleukin‐6 production and plasmablast differentiation …
MP Karampetsou, D Comte, A Suárez‐Fueyo, E Katsuyama, N Yoshida, ...Arthritis & Rheumatology 71 (1), 99-108, 2019201
18
2019
T cell–specific STAT3 deficiency abrogates lupus nephritis
N Yoshida, F He, VC KyttarisLupus 28 (12), 1468-1472, 2019201
17
2019
Interleukin 23 is elevated in the serum of patients with SLE
M Vukelic, A Laloo, VC KyttarisLupus 29 (14), 1943-1947, 2020202
16
2020
Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis
T Katsuyama, H Li, SM Krishfield, VC Kyttaris, VR MoultonRheumatology 60 (1), 420-429, 2021202
15
2021
Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: effect of timing and immunologic parameters
D Magliulo, SD Wade, VC KyttarisClinical Immunology 234, 108897, 2022202
15
2022
Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
SD Wade, VC KyttarisRheumatology International 41 (6), 1115-1124, 2021202
13
2021
Application of the 2019 European League Against Rheumatism/American College of Rheumatology systemic lupus erythematosus classification criteria in clinical practice: a single …
J Rubio, S Krishfield, VC KyttarisLupus 29 (4), 421-425, 2020202
12
2020
Estrogen‐Induced hsa‐miR‐10b‐5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down‐Regulates Serine/Arginine‐Rich Splicing Factor 1
Estrogen‐Induced hsa‐miR‐b‐5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down‐Regulates Serine/Arginine‐Rich Splicing Factor 1SA Ramanujan, EN Cravens, SM Krishfield, VC Kyttaris, VR MoultonArthritis & Rheumatology 73 (11), 2052-2058, 2021202
10
2021
Serine/threonine phosphatase PP2A is essential for optimal B cell function
E Meidan, H Li, W Pan, M Kono, S Yu, VC Kyttaris, C Ioannidis, ...JCI insight 5 (5), 2020202
9
2020
Targeting cytokines to treat autoimmunity
VC KyttarisClinical Immunology 206, 108251, 20120
9
2019
The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription
R Hisada, N Yoshida, M Umeda, C Burbano, R Bhargava, M Scherlinger, ...Cellular & Molecular Immunology 19 (6), 73-750, 2022202
8
2022
SLAMF1 engagement inhibits T cell-B cell interaction and diminishes IL-6 production and plasmablast differentiation in systemic lupus erythematosus
SLAMF1 engagement inhibits T cell-B cell interaction and diminishes IL- production and plasmablast differentiation in systemic lupus erythematosusMP Karampetsou, D Comte, DRA Suárez-Fueyo, E Katsuyama, ...Arthritis & rheumatology (Hoboken, NJ) 71 (1), 99, 2019201
6
2019
ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1
M Umeda, N Yoshida, R Hisada, C Burbano, SYK Orite, M Kono, ...Proceedings of the National Academy of Sciences 118 (18), e2023230118, 2021202
5
2021
Measuring IFN activity in suspected SLE: a valuable step?
J Rubio, VC KyttarisExpert Review of Clinical Immunology 17 (6), 55-58, 2021202
4
2021

Referred From: https://scholar.google.com/citations?user=ELNxPUgAAAAJ&hl=en

Cited by
Citations 6961
h-index 49
i10-index 90
Recommended Journals
Open Access Journals